Abstract | OBJECTIVE: To evaluate the efficacy of the 3 major classes of anthelmintics used for the treatment of hookworms in dogs in the US and an extralabel treatment with an FDA-approved product for use in cats in a Labrador kennel with a history of persistent hookworm infections. ANIMALS: 22 dogs housed in a single kennel comprised of the following breeds: 19 Labrador Retrievers, 1 English Cocker Spaniel, 1 Chesapeake Bay Retriever, and 1 Boykin Spaniel. PROCEDURES: RESULTS: CLINICAL RELEVANCE: These data demonstrate that the Ancylostoma caninum infecting the dogs in this kennel are highly resistant to all major anthelmintic classes approved for use in dogs in the US but are susceptible to emodepside. This was the first report of multiple anthelmintic drug-resistant A caninum in a dog kennel that does not involve Greyhounds.
|
Authors | Pablo D Jimenez Castro, Kendra Durrence, Stephen Durrence, Leonor Sicalo Gianechini, James Collins, Kayla Dunn, Ray M Kaplan |
Journal | Journal of the American Veterinary Medical Association
(J Am Vet Med Assoc)
Vol. 261
Issue 3
Pg. 342-347
(12 15 2022)
ISSN: 1943-569X [Electronic] United States |
PMID | 36520649
(Publication Type: Journal Article, Randomized Controlled Trial, Veterinary)
|
Chemical References |
- Anthelmintics
- Fenbendazole
- imidacloprid
- Macrolides
- milbemycin oxime
- moxidectin
- Praziquantel
- Pyrantel Pamoate
|
Topics |
- Animals
- Dogs
- Ancylostoma
- Ancylostomatoidea
- Anthelmintics
- Cat Diseases
(drug therapy)
- Dog Diseases
(drug therapy)
- Drug Resistance
- Feces
- Fenbendazole
- Georgia
- Macrolides
- Parasite Egg Count
(veterinary)
- Praziquantel
- Pyrantel Pamoate
(therapeutic use)
|